| Heterogeneity of screening effects |
Hormuzd Katki |
NCI |
NLST |
Jul 18, 2023 |
NLST-1098 |
| Development and validation of a deep learning-based method for lung cancer risk prediction in low-dose chest CT images |
Haewon Kim |
Keimyung University Dongsan Hospital |
NLST |
Jul 18, 2023 |
NLST-1097 |
| Application of Predictive Modelling Using Machine Learning Techniques to Predict Survival in Oncology |
Shanti Neff-Baro |
Amaris Consulting |
NLST |
Jul 18, 2023 |
NLST-1096 |
| Automated extraction of chest CT derived body composition biomarkers of tissue morphology and texture. |
Miranda Kirby |
Toronto Metropolitan University |
NLST |
Jul 18, 2023 |
NLST-1095 |
| Combination of imageomics and histopathology for prognostic analysis of non-small cell lung cancer |
Liangxing Li |
Southern Medical University |
NLST |
Jul 6, 2023 |
NLST-1092 |
| Development a risk-stratified tool of colonoscopy advanced and nonadvanced adenomas |
Le Wang |
Zhejiang Cancer Hospital |
PLCO |
Jul 6, 2023 |
PLCO-1268 |
| Associations of dietary carrot/carotene intakes with risk of cancer and overall and cause-specific mortality: results from the PLCO Cancer Screening Trial |
Yadong Li |
The Second Affiliated Hospital of chongqing medical university |
PLCO |
Jul 6, 2023 |
PLCO-1266 |
| Role of directly measured metabolic profile as an intermediate between adiposity and endometrial cancer: triangulation of evidence from independent sources |
Laure Dossus |
The International Agency for Research on Cancer, World Health Organization (IARC) |
PLCO |
Jul 3, 2023 |
PLCO-1265 |
| Research on CT Influence Omics Method of Lung Cancer Based on Deep Transfer Learning |
Xianwei Zhao |
NPIC |
NLST |
Jul 3, 2023 |
NLST-1091 |
| Methodologies for modeling clinical performance and utilities of a cancer screening test using NLST trial as an example |
James Dai |
GRAIL LLC |
NLST |
Jul 3, 2023 |
NLST-1090 |
| Blood-based biomarkers for personalized risk assessment of breast and ovarian cancers |
Johannes Fahrmann |
University of Texas MD Anderson Cancer Center |
PLCO |
Jul 1, 2023 |
2022-0048 |
| Time to benefit for lung cancer screening from low-dose computed tomography |
Tao Chen |
Xi'an Jiaotong University |
NLST |
Jun 26, 2023 |
NLST-1089 |
| Dietary intake of phytoestrogens and the risk of bladder cancer in the PLCO Screening Trial |
yadong Li |
The Second Affiliated Hospital of chongqing medical university |
PLCO |
Jun 22, 2023 |
PLCO-1261 |
| Characterizing the independent and joint contributions of the chemical, non-chemical, and social-structural environment on cancer incidence and mortality in the PLCO Study |
Jessica Madrigal |
Jessica Madrigal |
PLCO |
Jun 22, 2023 |
PLCO-1259 |
| Impact of treatment options on patient outcomes in hard - to - treat cancers: creating a personalized treatment framework using Machine Learning to address disparities in developed v. LMIC nations’ healthcare |
Georgia Perakis |
Massachusetts Institute of Technology |
PLCO |
Jun 22, 2023 |
PLCOI-1256 |
| In Silico Testing of Hypotheses for the Effect of Smoking on Somatic Evolution in the Healthy Human Lung |
Sam Janes |
University College London |
PLCO |
Jun 22, 2023 |
PLCO-1258 |
| Higher dietary anthocyanidins is associated with reduced risk of biliary cancer in the PLCO Cancer Screening Trial |
Ling Xiang |
Department of Clinical Nutrition, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. |
PLCO |
Jun 22, 2023 |
PLCO-1257 |
| Conceal-Reveal analysis |
Paul Pinsky |
NCI |
MINN |
Jun 20, 2023 |
MINN-4 |
| Improving lung cancer risk prediction with artificial intelligence |
Chiara Paganelli |
Politecnico di Milano |
NLST |
Jun 15, 2023 |
NLST-1087 |
| Development of a Nodule Risk Calculator using NLST Data |
Christopher Towe |
University Hospitals |
NLST |
Jun 15, 2023 |
NLST-1086 |
